News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
772,887 Results
Type
Article (51230)
Company Profile (342)
Press Release (721297)
Multimedia
Podcasts (133)
Webinars (26)
Section
Business (213930)
Career Advice (2198)
Deals (36879)
Drug Delivery (146)
Drug Development (83687)
Employer Resources (178)
FDA (17327)
Job Trends (15876)
News (361915)
Policy (35376)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2888)
Academic (2)
Accelerated approval (43)
Adcomms (29)
Allergies (169)
Alliances (52468)
ALS (197)
Alzheimer's disease (1826)
Antibody-drug conjugate (ADC) (402)
Approvals (17633)
Artificial intelligence (662)
Autoimmune disease (233)
Automation (52)
Bankruptcy (371)
Best Places to Work (12311)
BIOSECURE Act (21)
Biosimilars (216)
Biotechnology (207)
Bladder cancer (178)
Brain cancer (68)
Breast cancer (710)
Cancer (5538)
Cardiovascular disease (469)
Career advice (1871)
Career pathing (42)
CAR-T (315)
CDC (68)
Celiac Disease (2)
Cell therapy (836)
Cervical cancer (44)
Clinical research (71957)
Collaboration (2050)
Company closure (5)
Compensation (1305)
Complete response letters (79)
COVID-19 (2933)
CRISPR (109)
C-suite (1061)
Cystic fibrosis (156)
Data (7252)
Decentralized trials (3)
Denatured (47)
Depression (165)
Dermatology (65)
Diabetes (572)
Diagnostics (7265)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (318)
Drug pricing (219)
Drug shortages (32)
Duchenne muscular dystrophy (277)
Earnings (93282)
Editorial (69)
Employer branding (22)
Employer resources (156)
Events (128075)
Executive appointments (1103)
FDA (20905)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1726)
Gene editing (229)
Generative AI (65)
Gene therapy (690)
GLP-1 (1095)
Government (5309)
Grass and pollen (7)
Guidances (403)
Healthcare (20549)
HIV (79)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (287)
Immuno-oncology (87)
Indications (164)
Infectious disease (3280)
Inflammatory bowel disease (209)
Inflation Reduction Act (17)
Influenza (139)
Intellectual property (279)
Interviews (349)
IPO (17102)
IRA (54)
Job creations (3909)
Job search strategy (1550)
JPM (69)
Kidney cancer (18)
Labor market (95)
Layoffs (583)
Leadership (39)
Legal (8547)
Liver cancer (103)
Longevity (29)
Lung cancer (731)
Lymphoma (413)
Machine learning (55)
Management (61)
Manufacturing (979)
MASH (187)
Medical device (14740)
Medtech (14825)
Mergers & acquisitions (20982)
Metabolic disorders (1491)
mRNA (203)
Multiple sclerosis (180)
NASH (18)
Neurodegenerative disease (407)
Neuropsychiatric disorders (104)
Neuroscience (3289)
Neurotech (1)
NextGen: Class of 2026 (7179)
Non-profit (4982)
Now hiring (74)
Obesity (712)
Opinion (315)
Ovarian cancer (198)
Pain (244)
Pancreatic cancer (270)
Parkinson's disease (359)
Partnered (35)
Patents (570)
Patient recruitment (628)
Peanut (62)
People (62445)
Pharmaceutical (72)
Pharmacy benefit managers (35)
Phase 1 (22498)
Phase 2 (31531)
Phase 3 (23511)
Pipeline (7475)
Policy (344)
Postmarket research (2767)
Preclinical (9546)
Press Release (71)
Prostate cancer (287)
Psychedelics (54)
Radiopharmaceuticals (321)
Rare diseases (1051)
Real estate (6350)
Recruiting (71)
Regulatory (26715)
Reports (55)
Research institute (2649)
Resumes & cover letters (377)
Rett syndrome (33)
RNA editing (19)
RSV (92)
Schizophrenia (170)
Series A (290)
Series B (217)
Service/supplier (16)
Sickle cell disease (113)
Special edition (28)
Spinal muscular atrophy (171)
Sponsored (50)
Startups (3872)
State (2)
Stomach cancer (20)
Supply chain (134)
Tariffs (92)
The Weekly (84)
Vaccines (1178)
Venture capital (105)
Weight loss (461)
Women's health (119)
Worklife (20)
Date
Today (137)
Last 7 days (557)
Last 30 days (2635)
Last 365 days (31294)
2026 (9121)
2025 (31465)
2024 (36592)
2023 (41560)
2022 (52848)
2021 (57592)
2020 (56611)
2019 (49858)
2018 (37774)
2017 (33906)
2016 (34016)
2015 (40083)
2014 (33719)
2013 (28753)
2012 (30978)
2011 (31591)
2010 (29797)
Location
Africa (875)
Alabama (97)
Alaska (7)
Arizona (352)
Arkansas (16)
Asia (42769)
Australia (7079)
California (12695)
Canada (3607)
China (1287)
Colorado (547)
Connecticut (561)
Delaware (380)
Europe (94532)
Florida (1904)
Georgia (419)
Hawaii (4)
Idaho (68)
Illinois (1043)
India (86)
Indiana (593)
Iowa (23)
Japan (512)
Kansas (134)
Kentucky (50)
Louisiana (41)
Maine (87)
Maryland (1557)
Massachusetts (9186)
Michigan (380)
Minnesota (723)
Mississippi (7)
Missouri (154)
Montana (35)
Nebraska (29)
Nevada (143)
New Hampshire (88)
New Jersey (3428)
New Mexico (30)
New York (3376)
North Carolina (1687)
North Dakota (9)
Northern California (6256)
Ohio (395)
Oklahoma (26)
Oregon (43)
Pennsylvania (2551)
Puerto Rico (28)
Rhode Island (52)
South America (1253)
South Carolina (83)
South Dakota (2)
Southern California (5005)
Tennessee (202)
Texas (2026)
United States (45490)
Utah (386)
Vermont (1)
Virginia (311)
Washington D.C. (85)
Washington State (1031)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
772,887 Results for "vigil health solutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alloy Therapeutics Appoints Alexander Titus, Ph.D., to Lead New Vigilance Division Focused on Biosecurity and Rapid Therapeutic Response
April 1, 2026
·
3 min read
Neurodegenerative disease
Vigil’s TREM2 Antibody for Rare Brain Disease Flunks Phase II Trial
Disappointing results for iluzanebart come shortly after Vigil Neuroscience struck a buy-out deal with Sanofi, but analysts say the outcome is unsurprising and shouldn’t affect the deal.
June 4, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
August 6, 2025
·
5 min read
Press Releases
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
April 3, 2026
·
11 min read
Press Releases
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
April 3, 2026
·
11 min read
Press Releases
Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings
March 30, 2026
·
5 min read
Alzheimer’s disease
Vigil’s TREM2-Targeted Alzheimer’s Treatment Shows Early Promise, Moves On to Phase II
Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially representing a new avenue for treating Alzheimer’s disease.
January 23, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
·
8 min read
Press Releases
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
March 23, 2026
·
5 min read
Press Releases
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
February 18, 2026
·
1 min read
1 of 77,289
Next
